#I looked up Bexxar, it has a whopping 4 black box warnings.
#(S1 (S (S (NP (PRP I)) (VP (VBD looked) (PRT (RP up)) (NP (NNP Bexxar)))) (, ,) (NP (PRP it)) (VP (AUX has) (NP (DT a) (JJ whopping) (CD 4) (JJ black) (NN box) (NNS warnings))) (. .)))
#Rule:Nouns
r1BexxarOrganizationAnnotation
r1boxNN
r1warningsNNS

#Rule:V-PRT
r3lookedVBDupRP

#Rule:Adjs
r4whoppingJJ
r4blackJJ

#Rule:Adj-Noun
r5whoppingJJwarningsNNS
r54CDwarningsNNS
r5blackJJwarningsNNS

#Rule:N-HeadNoun
r8boxNNwarningsNNS

#Rule:HeadNoun-V
r11itPRPhasAUX
r11iPRPlookedVBD

#Rule:V-HeadNoun
r21lookedVBDBexxarOrganizationAnnotation
r21hasAUXwarningsNNS

#  * Hypersensitivity reactions (including anaphylaxis) have been reported.
#(S1 (S (NP (NP (CD *) (JJ Hypersensitivity) (NNS reactions)) (PRN (-LRB- -LRB-) (VP (VBG including) (NP (NNS anaphylaxis))) (-RRB- -RRB-))) (VP (AUX have) (VP (AUX been) (VP (VBN reported)))) (. .)))
#Rule:Nouns
r1reactionsNNS
r1anaphylaxisOrganizationAnnotation

#Rule:Verbs
r2includingVBG
r2reportedVBN

#Rule:Adjs
r4HypersensitivityJJ

#Rule:Adj-Noun
r5*CDreactionsNNS
r5HypersensitivityJJreactionsNNS

#Rule:V-HeadNoun
r21includingVBGanaphylaxisOrganizationAnnotation

#Rule:V-HeadNoun(passive)
r23reportedVBNreactionsNNS

# Patients should be screened for human antimouse antibodies (HAMA);
#(S1 (S (NP (NNS Patients)) (VP (MD should) (VP (AUX be) (VP (VBN screened) (PP (IN for) (NP (NP (JJ human) (JJ antimouse) (NNS antibodies)) (PRN (-LRB- -LRB-) (NP (NNP HAMA)) (-RRB- -RRB-))))))) (: ;)))
#Rule:Nouns
r1PatientsNNS
r1antibodiesNNS
r1HAMAOrganizationAnnotation

#Rule:Verbs
r2screenedVBN

#Rule:Adjs
r4humanJJ
r4antimouseJJ

#Rule:Adj-Noun
r5humanJJantibodiesNNS
r5antimouseJJantibodiesNNS

#Rule:V-HeadNoun(passive)
r23screenedVBNPatientsNNS

#Rule:PPinVP
r32screenedVBNforINantibodiesNNS

# may be at increased risk of allergic or serious hypersensitivity reactions.
#(S1 (S (VP (MD may) (VP (AUX be) (PP (IN at) (NP (NP (VBN increased) (NN risk)) (PP (IN of) (NP (JJ allergic) (CC or) (JJ serious) (NN hypersensitivity) (NNS reactions))))))) (. .)))
#Rule:Nouns
r1riskNN
r1hypersensitivityNN
r1reactionsNNS

#Rule:Verbs
r2increasedVBN

#Rule:Adjs
r4allergicOrganizationAnnotation
r4seriousJJ

#Rule:Adj-Noun
r5increasedVBNriskNN
r5allergicOrganizationAnnotationreactionsNNS
r5seriousJJreactionsNNS

#Rule:N-HeadNoun
r8hypersensitivityNNreactionsNNS

#Rule:PPinNP
r26riskNNofINreactionsNNS

#Rule:PPinVP
r30beAUXatINriskNN

# Hematologic toxicity was reported to be the most common adverse effect with 27% patients requiring supportive care.
#(S1 (S (NP (JJ Hematologic) (NN toxicity)) (VP (AUX was) (VP (VBN reported) (S (VP (TO to) (VP (AUX be) (NP (NP (DT the) (ADJP (RBS most) (JJ common)) (JJ adverse) (NN effect)) (PP (IN with) (NP (NP (ADJP (CD 27) (NN %)) (NNS patients)) (VP (VBG requiring) (NP (ADJP (JJ supportive)) (NN care))))))))))) (. .)))
#Rule:Nouns
r1toxicityNN
r1effectNN
r1%NN
r1patientsNNS
r1careNN

#Rule:Verbs
r2reportedVBN
r2requiringVBG

#Rule:Adjs
r4HematologicOrganizationAnnotation
r4commonJJ
r4adverseJJ
r4supportiveJJ

#Rule:Adj-Noun
r5HematologicOrganizationAnnotationtoxicityNN
r5commonJJeffectNN
r5adverseJJeffectNN
r527CDpatientsNNS
r5supportiveJJcareNN

#Rule:HeadNoun-V
r11patientsNNSrequiringVBG

#Rule:V-HeadNoun
r21beAUXeffectNN
r21requiringVBGcareNN

#Rule:V-HeadNoun(passive)
r23reportedVBNtoxicityNN

#Rule:PPinNP
r26effectNNwithINpatientsNNS

# * Severe or life-threatening cytopenias (NCI CTC grade 3 or 4) have been reported in a large number of patients;
#(S1 (S (NP (NP (JJ *) (ADJP (JJ Severe) (CC or) (JJ life-threatening)) (NNS cytopenias)) (PRN (-LRB- -LRB-) (NP (NNP NCI) (NNP CTC)) (NP (NN grade) (CD 3) (CC or) (CD 4)) (-RRB- -RRB-))) (VP (AUX have) (VP (AUX been) (VP (VBN reported) (PP (IN in) (NP (NP (DT a) (JJ large) (NN number)) (PP (IN of) (NP (NNS patients)))))))) (: ;)))
#Rule:Nouns
r1cytopeniasNNS
r1NCI CTCOrganizationAnnotation
r1gradeNN
r1numberNN
r1patientsNNS

#Rule:Verbs
r2reportedVBN

#Rule:Adjs
r4*OrganizationAnnotation
r4SevereJJ
r4life-threateningJJ
r4largeJJ

#Rule:Adj-Noun
r5*OrganizationAnnotationcytopeniasNNS
r5SevereJJcytopeniasNNS
r5life-threateningJJcytopeniasNNS
r53CDgradeNN
r54CDgradeNN
r5largeJJnumberNN

#Rule:V-HeadNoun(passive)
r23reportedVBNcytopeniasNNS

#Rule:PPinNP
r26numberNNofINpatientsNNS

#Rule:PPinVP
r32reportedVBNinINnumberNN

# may be prolonged and severe.
#(S1 (S (VP (MD may) (VP (AUX be) (ADJP (JJ prolonged) (CC and) (JJ severe)))) (. .)))
#Rule:Adjs
r4prolongedJJ
r4severeJJ

#Rule:V-ADJ
r25beAUXprolongedJJ

# Secondary malignancies have been reported following use.
#(S1 (S (NP (JJ Secondary) (NNS malignancies)) (VP (AUX have) (VP (AUX been) (VP (VBN reported) (PP (VBG following) (NP (NN use)))))) (. .)))
#Rule:Nouns
r1malignanciesNNS
r1useNN

#Rule:Verbs
r2reportedVBN
r2followingVBG

#Rule:Adjs
r4SecondaryJJ

#Rule:Adj-Noun
r5SecondaryJJmalignanciesNNS

#Rule:V-HeadNoun(passive)
r23reportedVBNmalignanciesNNS

# * Treatment involves radioactive isotopes;
#(S1 (S (NP (NNP *) (NNP Treatment)) (VP (VBZ involves) (NP (JJ radioactive) (NNS isotopes))) (: ;)))
#Rule:Nouns
r1* TreatmentOrganizationAnnotation
r1isotopesLocationAnnotation

#Rule:Verbs
r2involvesVBZ

#Rule:Adjs
r4radioactiveJJ

#Rule:Adj-Noun
r5radioactiveJJisotopesLocationAnnotation

#Rule:HeadNoun-V
r11* TreatmentOrganizationAnnotationinvolvesVBZ

#Rule:V-HeadNoun
r21involvesVBZisotopesLocationAnnotation

# appropriate precautions in handling and administration must be followed.
#(S1 (S (NP (NP (JJ appropriate) (NNS precautions)) (PP (IN in) (NP (NN handling) (CC and) (NN administration)))) (VP (MD must) (VP (AUX be) (VP (VBN followed)))) (. .)))
#Rule:Nouns
r1precautionsNNS
r1handlingNN
r1administrationNN

#Rule:Verbs
r2followedVBN

#Rule:Adjs
r4appropriateJJ

#Rule:Adj-Noun
r5appropriateJJprecautionsNNS

#Rule:V-HeadNoun(passive)
r23followedVBNprecautionsNNS

#Rule:PPinNP
r26precautionsNNSinINhandlingNN

# Patients must be instructed in measures to minimize exposure of others.
#(S1 (S (NP (NNS Patients)) (VP (MD must) (VP (AUX be) (VP (VBN instructed) (PP (IN in) (NP (NP (NNS measures)) (SBAR (S (VP (TO to) (VP (VB minimize) (NP (NP (NN exposure)) (PP (IN of) (NP (NNS others))))))))))))) (. .)))
#Rule:Nouns
r1PatientsNNS
r1measuresNNS
r1exposureNN
r1othersNNS

#Rule:Verbs
r2instructedVBN
r2minimizeVB

#Rule:HeadNoun-(who/that)-V
r14measuresNNSminimizeVB

#Rule:V-HeadNoun
r21minimizeVBexposureNN

#Rule:V-HeadNoun(passive)
r23instructedVBNPatientsNNS

#Rule:PPinNP
r26exposureNNofINothersNNS

#Rule:PPinVP
r32instructedVBNinINmeasuresNNS

#*Women of childbearing potential should be advised of potential fetal risk..And
#(S1 (S (NP (NP (NNP *) (NNP Women)) (PP (IN of) (NP (JJ childbearing) (NN potential)))) (VP (MD should) (VP (AUX be) (VP (VBN advised) (PP (IN of) (NP (NP (JJ potential) (JJ fetal) (NN risk)) (VP (VBN ..) (NP (NNP And))))))))))
#Rule:Nouns
r1*NNP
r1WomenNNP
r1potentialNN
r1riskNN
r1AndNNP

#Rule:Verbs
r2advisedVBN
r2..VBN

#Rule:Adjs
r4childbearingJJ
r4potentialJJ
r4fetalJJ

#Rule:Adj-Noun
r5childbearingJJpotentialNN
r5potentialJJriskNN
r5fetalJJriskNN

#Rule:N-HeadNoun
r8*NNPWomenNNP

#Rule:V-HeadNoun
r21..VBNAndNNP

#Rule:V-HeadNoun(passive)
r23advisedVBNWomenNNP

#Rule:V-HeadNoun(passive)
r24..VBNriskNN

#Rule:PPinNP
r26WomenNNPofINpotentialNN

#Rule:PPinVP
r32advisedVBNofINriskNN

#And you wonder why doctors are not prescribing it more often?  I get so tired of people that think there is a magic pill out there that cures disease without side effects and the doctors are just refusing to give it to them.
#(S1 (S (CC And) (NP (PRP you)) (VP (VBP wonder) (SBAR (WHADVP (WRB why)) (S (NP (NNS doctors)) (VP (AUX are) (RB not) (VP (VBG prescribing) (NP (PRP it)) (ADVP (RBR more) (RB often))))) (. ?) (S (NP (PRP I)) (VP (VBP get) (ADJP (RB so) (JJ tired) (PP (IN of) (NP (NP (NNS people)) (SBAR (WHNP (WDT that)) (S (VP (VBP think) (SBAR (S (S (NP (EX there)) (VP (AUX is) (NP (DT a) (JJ magic) (NN pill)) (ADVP (IN out) (RB there)) (NP (DT that) (NNS cures) (NN disease)) (PP (IN without) (NP (NN side) (NNS effects))))) (CC and) (S (NP (DT the) (NNS doctors)) (VP (AUX are) (ADVP (RB just)) (VP (VBG refusing) (S (VP (TO to) (VP (VB give) (NP (PRP it)) (PP (TO to) (NP (PRP them))))))))))))))))))))) (. .)))
#Rule:Nouns
r1doctorsNNS
r1peopleNNS
r1pillNN
r1curesNNS
r1diseaseNN
r1sideNN
r1effectsNNS
r1doctorsNNS

#Rule:Verbs
r2wonderVBP
r2prescribingVBG
r2getVBP
r2thinkVBP
r2refusingVBG
r2giveVB

#Rule:Adjs
r4tiredJJ
r4magicJJ

#Rule:Adj-Noun
r5magicJJpillNN

#Rule:N-HeadNoun
r8curesNNSdiseaseNN
r8sideNNeffectsNNS

#Rule:HeadNoun-V
r11youPRPwonderVBP
r11doctorsNNSprescribingVBG
r11iPRPgetVBP
r11thereEXisAUX
r11doctorsNNSrefusingVBG

#Rule:HeadNoun-(who/that)-V
r14peopleNNSthinkVBP

#Rule:V-HeadNoun
r21prescribingVBGitPRP
r21isAUXpillNN
r21isAUXdiseaseNN
r21giveVBitPRP

#Rule:PPinVP
r30isAUXwithoutINeffectsNNS
r30giveVBtoTOthemPRP

#Rule:PPinADJP
r37tiredJJofINpeopleNNS

#Rule:V-V
r44refusingVBGgiveVB

#Rule:V-ADV
r46areAUXnotRB
r46prescribingVBGoftenRB
r46isAUXthereRB
r46areAUXjustRB
r46refusingVBGjustRB

@lemmas-left	instructed	prescribe	involve	people	cure	are	report	Severe	fetal	doctors	serious	black	cures	screen	reported	others	* Treatment	%	antibodies	*	effects	number	27	include	3	hypersensitivity	magic	4	tired	malignancy	measures	reaction	give	common	Women	secondary	advise	use	handling	followed	Secondary	precaution	pill	cytopenia	Hypersensitivity	patients	patient	advised	allergic	side	grade	warnings	look	malignancies	i	including	precautions	NCI CTC	warning	Bexxar	HAMA	requiring	anaphylaxis	screened	has	doctor	toxicity	instruct	woman	..	wonder	care	be	follow	think	involves	appropriate	get	cytopenias	Patients	and	refuse	childbearing	require	life-threatening	whopping	large	administration	And	prolonged	exposure	measure	increased	antibody	have	reactions	isotopes	antimouse	disease	adverse	risk	following	supportive	severe	refusing	is	it	potential	you	minimize	human	effect	Hematologic	looked	there	increase	box	prescribing	radioactive	
@lemmas-right	Bexxar	prescribe	involve	requiring	anaphylaxis	people	has	toxicity	woman	care	wonder	be	think	involves	others	get	antibodies	cytopenias	Patients	number	effects	and	not	refuse	often	them	malignancy	require	measures	And	reaction	prolonged	exposure	measure	give	have	reactions	antibody	isotopes	Women	disease	handling	risk	precaution	cytopenia	pill	patients	patient	grade	warnings	refusing	just	look	is	malignancies	it	potential	minimize	up	effect	looked	there	precautions	prescribing	warning	
@lemmas-center	to	of	with	for	at	without	in	